Newly established firm puts down roots in Denmark

US pharmaceutical company MSD has established a spinout company, Organon, which will have an office in Copenhagen. Organon focuses on women's health.

Jennifer Olovson, head of Nordics, Organon. | Photo: Organon/PR

Pharmaceutical group MSD, known as Merck in the US and Canada, has now officially launched its spinout company Organon. It will have offices all over the world, including in Copenhagen.

"There is a huge need for a company like Organon. This need has existed for a long time, and I am very proud that we can now execute our launch, which we have been planning for such a long time, and have huge ambitions for," says Jennifer Olovson, head of Nordics at Organon.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs